ADXN: Addex Therapeutics Ltd. Bozor kapitallashuvining daromadga nisbati
Addex Therapeutics (ADXN) aksiyalar narxining ko'tarilishi Parkinson kasalligi terapiyasi va patentlaridagi yutuqlar bilan bog'liq. Ishonchli xomashyo yetkazib beruvchilar tarmog'i sinovlarning uzluksizligini ta'minlaydi. Kompaniyaning o'rtacha P/S ko'rsatkichi biznesning baholanish tendentsiyasini aks ettiradi va ayni paytda ushbu ko'rsatkich 56.40 darajasida turibdi. Moliyaviy model innovatsion kichik molekulalarni ishlab chiqish uchun global sog'liqni saqlash gigantlari-hamkorlaridan keladigan grantlar va to'lovlarga tayanadi.
Addex Therapeutics, Ltd. (ADXN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Addex Therapeutics|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Addex|ADXN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Addex Therapeutics, Ltd.|ADXN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Addex Therapeutics|Oraliq likvidlik koeffitsiyenti addextherapeutics.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
ADXN - Sof foyda|Kompaniya foydasi prognozi Addex Therapeutics|ADXN - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Addex Therapeutics Ltd.|ADXN - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Addex Therapeutics, Ltd.|ADXN - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Addex Therapeutics|ADXN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi addextherapeutics.com|ADXN - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Addex Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ADXN - addextherapeutics.com
Yuqori sifatli portfelni shakllantirish uchun men P/S koeffitsiyentidan foydalanaman, u tushumning bir dollari bozor qiymatini aniqlaydi va joriy daromadlilikdan qat'i nazar, biznes premiumini baholash imkonini beradi. R&D va strategik hamkorlarni qidirishga e'tibor qaratgan Addex Therapeutics (ADXN) holatida, P/S tarixi allosterik modulatorlarning tijoratlashtirilishiga nisbatan bozor kutganlarini haqiqiy savdo hajmlari bilan solishtirgan holda aks ettiradi.
Addex Therapeutics kimlar bilan raqobatlashadi
Kapitalizatsiyaning sotish hajmiga nisbati BIIB|P/S multiplikatori NBIX (Neurocrine Biosciences, Inc.)|Bozor kapitallashuvining daromadga nisbati RGC|Axsome Therapeutics Inc - P/S multiplikatori|Sotuvga nisbatan narx ACADIA Corp|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|vikingtherapeutics.com - Bozor kapitallashuvining daromadga nisbati|SUPN (Supernus) - P/S multiplikatori|P/S multiplikatori Catalyst Pharma|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|HRMY: Narxning sotuvga nisbati|P/S multiplikatori BHVN (Biohaven Ltd.)|amylyx.com (AMLX) - Sotuvga nisbatan narx|TRVI: Kapitalizatsiyaning daromadga nisbati|PRAX - P/S multiplikatori|AVXL (Anavex Corp) - Kapitalizatsiyaning daromadga nisbati|CBLL: Kapitalizatsiyaning sotish hajmiga nisbati|PRTA (Prothena Biosciences) - P/S multiplikatori|Alector Therapeutics (ALEC) - Narx/daromad koeffitsiyenti|P/S multiplikatori ANNX|Kapitalizatsiyaning daromadga nisbati omeros.com OMER|Narxning daromadga nisbati Neurogene Corp NGNE|Narx/daromad koeffitsiyenti AC Immune Inc (ACIU)|Voyager Therapeutics - P/S multiplikatori|NMRA - P/S multiplikatori|SCLX: P/S multiplikatori|Kapitalizatsiya va daromad nisbati TVGN|Kapitalizatsiyaning daromadga nisbati ACOG|Kapitalizatsiya va daromad nisbati CGTX (Cognition Therapeutics Inc.)|Narxning daromadga nisbati Inhibikase Therapeutics (IKT)|cassavasciences.com - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Assertio ASRT|COYA: Kapitalizatsiya va daromad nisbati|VistaGen Therapeutics Inc - P/S multiplikatori|Sotuvga nisbatan narx Ovid Therapeutics Inc.|ABOS (Acumen Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|cervomed.com (CRVO) - P/S multiplikatori|Narxning daromadga nisbati Alterity Therapeutics Ltd.|CLNN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati PepGen Inc. (PEPG)|JUNS - Sotuvga nisbatan narx|P/S multiplikatori RLMD (Relmada Therapeutics)|P/S multiplikatori annovisbio.com ANVS|Grace Tx - P/S multiplikatori|AIFF (Firefly Neuroscience, Inc.) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|Kapitalizatsiya va daromad nisbati NRSN|RVPH (Reviva Pharmaceuticals) - P/S multiplikatori|Sotuvga nisbatan narx MetaVia, Inc. MTVA|Kapitalizatsiyaning daromadga nisbati NRXS (NeurAxis)|heliusmedical.com - Kapitalizatsiya va daromad nisbati|Passage Bio - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati NEUP|NERV: Kapitalizatsiyaning daromadga nisbati|athira.com - Kapitalizatsiyaning sotish hajmiga nisbati|ALZN: P/S multiplikatori|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining daromadga nisbati|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Sotuvga nisbatan narx Pasithea KTTA|Narxning daromadga nisbati Cortigent, Inc. (CRGT)|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|P/S multiplikatori Cara Therapeutics Inc. CARA|CHRO - Narxning daromadga nisbati|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx longboardpharma.com (LBPH)|Kapitalizatsiyaning daromadga nisbati MRNS|P/S multiplikatori NKGen Biotech Inc|Kapitalizatsiyaning daromadga nisbati NRBO (NeuroBo)|Kapitalizatsiyaning sotish hajmiga nisbati SAGE|P/S multiplikatori SNPX (Synaptogenix, Inc.)|Narx/daromad koeffitsiyenti trevena.com (TRVN)|Vigil Neuro - P/S multiplikatori|anewmeds.com (WENA) - Kapitalizatsiyaning daromadga nisbati|Cerevel (CERE) - Narxning daromadga nisbati
